A PILOT STUDY TO INVESTIGATE THE SAFETY, EFFICACY, PHARMACOKINETICS AND BIOAVAILABILITY OF HTX-011, HTX-002, OR HTX-009 ADMINISTERED VIA INJECTION AND/OR TOPICAL APPLICATION FOLLOWING UNILATERAL OPEN INGUINAL HERNIORRHAPHY: